Onconetix Inc (NASDAQ: ONCO)’s stock price has increased by 5.28 compared to its previous closing price of 0.07. However, the company has seen a 0.13% increase in its stock price over the last five trading sessions. accessnewswire.com reported 2025-03-26 that VANCOUVER, BC / ACCESS Newswire / March 26, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) (“Onco” or the “Company”) is pleased to provide information regarding its second-generation nanoparticle formulation of Polynucleotide Kinase 3′-Phosphatase (PNKP) Compound (the “Technology”) in combination with radiation therapy, which has demonstrated, in a December 2021 study[1] conducted by researchers at the University of Alberta, Canada, effective targeting of cancer cells in mice while, importantly, maintaining a low toxicity profile. The low toxicity observed in the study, even at therapeutic doses in mice with colorectal cancer, and especially when combined with radiation therapy, is particularly significant, as it suggests the potential for a solution with fewer side effects, which could lead to the development of safer and more effective treatment options.
Is It Worth Investing in Onconetix Inc (NASDAQ: ONCO) Right Now?
Additionally, the 36-month beta value for ONCO is 3.05. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for ONCO is 9.39M and currently, short sellers hold a 7.86% ratio of that float. The average trading volume of ONCO on April 08, 2025 was 6.81M shares.
ONCO’s Market Performance
ONCO stock saw a decrease of 0.13% in the past week, with a monthly decline of -58.35% and a quarterly a decrease of -89.19%. The volatility ratio for the week is 13.70%, and the volatility levels for the last 30 days are 18.15% for Onconetix Inc (ONCO). The simple moving average for the last 20 days is -28.33% for ONCO stock, with a simple moving average of -97.37% for the last 200 days.
ONCO Trading at -75.34% from the 50-Day Moving Average
After a stumble in the market that brought ONCO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.65% of loss for the given period.
Volatility was left at 18.15%, however, over the last 30 days, the volatility rate increased by 13.70%, as shares sank -59.83% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -88.89% lower at present.
During the last 5 trading sessions, ONCO fell by -5.55%, which changed the moving average for the period of 200-days by -98.85% in comparison to the 20-day moving average, which settled at $0.1055. In addition, Onconetix Inc saw -87.97% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ONCO
Current profitability levels for the company are sitting at:
- -13.5 for the present operating margin
- -0.41 for the gross margin
The net margin for Onconetix Inc stands at -27.59. The total capital return value is set at -0.57. Equity return is now at value -233.77, with -114.93 for asset returns.
Based on Onconetix Inc (ONCO), the company’s capital structure generated 0.23 points at debt to capital in total, while cash flow to debt ratio is standing at -1.39. The debt to equity ratio resting at 0.29. The interest coverage ratio of the stock is -18.73.
Currently, EBITDA for the company is -36.71 million with net debt to EBITDA at -0.19. When we switch over and look at the enterprise to sales, we see a ratio of 5.74. The receivables turnover for the company is 19.08for trailing twelve months and the total asset turnover is 0.03. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.06.
Conclusion
In conclusion, Onconetix Inc (ONCO) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
